PRLog (Press Release) –
Jan 17, 2008 – OrthoMediTec is a privately held medical device company, specializing in the field of orthopedic trauma solutions. The company provides surgeons with devices for the treatment of patients in orthopedic trauma care. WaisFix100™ is a groundbreaking solution for the treatment of proximal femoral fracture, a major market within trauma care. Current fixation failure rates for femoral fractures are high using current surgical methods; fractures have average failure rates of up to 45%. WaisFix100™ is the first commercially available device that reduces morbidity and mortality by increasing recovery rates and reducing blood loss and damage to tissue. The WaisFix100™ fixation device is designed to provide benefits such as minimally invasive accelerated fixation and early weight-bearing.
Approval from the Ministry of Health (AMA”R) was granted in June, 2007. First three cases successfully performed at the Carmel medical centre, Haifa, Israel.
Equity Source Corporate Technology reports that the number of global hip fractures (occidental world) performed on a yearly basis has been estimated at 1,080,000-1,500,000 per annum, with the total yearly trauma products market size is estimated at $856 million, with an annual growth of approximately 7%.
(www.equitysource.co.uk)
(www.orthomeditec.com)
With its head office in the United Kingdom, Equity Source is the only independent corporate technology firm focused on identifying valuable developments and facilitating new strategic partnerships.
